| Company/Division name | EMD Serono |
| Parent company | Merck KGaA |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2019 |
| Year reshoring implemented or to be implemented: | 2021 |
| Capital investment ($): | 70 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Billerica |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Skilled workforce availability/training |
